Follow Flash Finance FollowTelegram
52tech score
/ 100

Dr Agarwal's Eye (DRAGARWQ) — Technical Setup

₹5,411.50 +1.77%   Uptrend Volatility Expansion Neutral

As of 2026-11-02 close Sector: Healthcare Hospital All technical setups →

Summary

Dr Agarwal's Eye is in a uptrend on the daily chart. RSI(14) is 62.7, MACD is above its signal line, ADX reads 19 (weak trend). Volume in the latest session was 0.6× its 20-day average. Over three months it has outperformed the Nifty 50 by 11.6 percentage points. Nearest support is ₹5,162.50 and resistance ₹5,500.00. Its technical score is 52/100 (neutral).

Trend (daily)
Bullish
Trend (weekly)
—
Trend (monthly)
—
RSI (14)
62.71
MACD
Bullish
ADX (14)
18.51
Volume vs 20d avg
0.64×
Support
₹5,162.50 (−4.6%)
Resistance
₹5,500.00 (+1.6%)
RS vs Nifty (3M)
+11.61%
RS rating
75.00

🧮 How the 52/100 is built

Five components, 20 points each. Every rule is shown with the points it earned — the score describes the chart as it stands today; it is not a prediction.

Trend10/20
  • Close above 20-day EMA (4.20)3/3
  • 20-day EMA above 50-day EMA3/3
  • 50-day EMA above 200-day EMA0/3
  • Close above 200-day SMA0/3
  • SuperTrend (10,3) pointing up3/3
  • ADX ≥ 20 with +DI above −DI (trend has strength) (18.51)1/3
  • Weekly trend up (above a rising 30-week average)0/2
Momentum20/20
  • RSI(14) in the bullish zone (55-70 best) (62.71)6/6
  • MACD line above its signal line4/4
  • MACD line above zero (21.12)3/3
  • 12-day rate of change positive (5.12)3/3
  • Stochastic %K above %D2/2
  • Outperforming the Nifty 50 over 3 months (11.61)2/2
Volume5/20
  • On-balance volume rising over 20 sessions0/5
  • Chaikin Money Flow (20) positive (-0.14)0/5
  • More volume on up days than down days (20 sessions) (0.67)0/5
  • Close above 20-day VWAP (5.38)5/5
Volatility10/20
  • Daily range (ATR%) contained — ≤2.5% scores full (2.98)4/6
  • Price in the upper half of its Bollinger Bands (1.10)3/5
  • Shallow drawdown from the 52-week high (-10.70)3/5
  • Volatility contracting (20-day volatility below its 6-month median) (69.30)0/4
Support / Resistance7/20
  • Room to the next resistance (≥8% scores full) (1.64)0/5
  • Support close below (a tight, definable stop) (4.60)5/5
  • Broke above a 20-day high in the last 5 sessions0/5
  • Within 5% of the 52-week high (-10.70)2/5

🧭 Regime: Uptrend

Volatility Expansion — Bollinger width is in the 88th percentile of the last six months.

Suits: Trend-following, selectively. The trend is up but not forceful — favour entries near support and keep stops below the 50-day EMA.

Classified from ADX, the 20/50-day EMA stack and price's distance from the 50-day average; volatility from band-width and ATR expansion.

Opens the AI Backtester with the 20/50 EMA Crossover rules for DRAGARWQ — 20-day ema crosses above the 50-day ema.

🕰️ Multi-timeframe

TimeframeTrendRSI (14)MACD hist.
Monthly———
Weekly———
Daily▲ Bullish62.7135.91

Weekly: close vs a rising 30-week average (Weinstein). Monthly: close vs the 10-month average. Weekly SuperTrend: —, weekly ADX —.

📶 Volume & VWAP

Relative volume
0.64×
5d / 20d volume
0.40×
Volume ROC (10d)
-52.70%
Up/down volume
0.67×
OBV (20d)
Falling / flat
Chaikin MF (20)
-0.14
VWAP 20d
₹5,135.04 (+5.38%)
VWAP 50d
₹5,212.62 (+3.82%)
Anchored VWAP · 52W low
₹5,161.07 (+4.85%)
Anchored VWAP · 52W high
₹5,173.96 (+4.59%)
Anchored VWAP · YTD
₹5,160.96 (+4.85%)
Avg turnover (20d)
₹0.91 Cr

VWAPs are computed from daily bars (typical price × volume), not intraday ticks. Volume has dried up to under 60% of normal. Warning: price rose over 20 sessions while OBV fell (bearish price-volume divergence).

💪 Relative strength

vs Nifty 1M
+1.86%
vs Nifty 3M
+11.61%
vs Nifty 6M
+11.21%
vs Nifty 1Y
—
RS rating
75.00
Mansfield RS
—
vs Healthcare index 3M
+9.39%
vs sector peers 3M
+16.76%

DRAGARWQ ÷ Nifty 50, rebased to 100 a year ago. Rising = outperforming.

🧱 Support & resistance

Clustered swing highs and lows from the last year; “touches” is how many swings formed the level.

LevelPriceDistanceTouches
Resistance₹6,059.70+12.0%1
Resistance₹5,600.00+3.5%1
Resistance₹5,500.00+1.6%1
Close₹5,411.50—
Support₹5,162.50−4.6%9
Support₹4,813.50−11.1%3
Support₹4,600.00−15.0%1

52-week range: ₹4,600.00 – ₹6,059.70 (-10.70% from the high).

🌀 Fibonacci

Measuring the down-swing from ₹6,059.70 (2026-05-21) to ₹4,600.00 (2026-05-21). Price has retraced 55.6% of it.

RatioPriceDistance
23.6% retracement₹4,944.49-8.6%
38.2% retracement₹5,157.61-4.7%S/R confluence
50.0% retracement₹5,329.85-1.5% nearest
61.8% retracement₹5,502.09+1.7%S/R confluence
78.6% retracement₹5,747.32+6.2%
127.2% extension₹4,202.96-22.3%
161.8% extension₹3,697.91-31.7%
200.0% extension₹3,140.30-42.0%

🕯️ Candlesticks (last 5 sessions)

Quality combines the pattern's reliability with its context: prior trend, volume, a support/resistance level and RSI.

↗️ Divergences

No regular divergence on RSI, MACD, OBV, MFI or Stochastic at the latest swings.

🏭 Healthcare peers by technical score
Stock Close Chg Score Trend regimeRS rating (1-99)
AGARWALEYEDr. Agarwal's Health Care Limited ₹513.85 +0.91% 84 Range 75.00
APOLLOHOSPApollo Hospitals Enterprise Limited ₹8,459.00 +0.13% 74 Range 73.00
INDGNIndegene Limited ₹619.40 +5.56% 71 Uptrend 84.00
NHNarayana Hrudayalaya Ltd. ₹1,834.20 +6.63% 69 Range 64.00
SYNGENESyngene International Limited ₹412.95 +2.55% 67 Range 43.00
VIJAYAVijaya Diagnostic Centre Limited ₹1,457.40 +0.81% 67 Range 87.00
METROPOLISMetropolis Healthcare Limited ₹559.90 +2.61% 59 Range 76.00
SURAKSHASuraksha Diagnostic Limited ₹325.45 +2.88% 54 Range 83.00
GAUDIUMIVFGaudium IVF and Women Health Limited ₹105.64 -0.21% 51 Weak Downtrend 27.00
MEDANTAGlobal Health Limited ₹1,298.40 +2.21% 46 Weak Downtrend 71.00
🔗 More on DRAGARWQ

⚠️ Educational technical analysis computed automatically from end-of-day NSE prices — not investment advice. Flash Finance is not SEBI-registered. Indicators describe what price has done; they do not predict what it will do. Verify levels on a live chart and manage risk before acting.

⚠️ How this site is made: Market data pages are computed automatically from NSE/BSE publications and company filings; news articles and announcement analyses are written with AI assistance, with a human in the loop: our editors review what the AI produces. Both can contain errors. Verify with the original sources before any investment decision. Not investment advice; Flash Finance is not SEBI-registered. How we use AI